Cardiovascular failure, including cardiogenic shock, requires prompt hemodynamic support to maintain adequate cardiac output and organ perfusion. This is primarily achieved using inotropic agents and vasopressors .
Inotropes
- Definition: Drugs that alter the force of cardiac muscle contraction.
- Types:
- Positive inotropes: Increase myocardial contractility → stronger heartbeats → improved cardiac output.
- Negative inotropes: Decrease contractility and heart rate → used in conditions like hypertension, arrhythmias, and angina.
Positive inotropes are crucial in managing heart failure, cardiomyopathy, recent myocardial infarction, and cardiogenic shock.
Vasopressors
- Definition: Drugs that cause vasoconstriction, increasing vascular tone and blood pressure.
- Used mainly in vasodilatory shock states (e.g., septic shock) and sometimes in cardiovascular failure when vascular tone is low.
Common Inotropes in Cardiovascular Failure
| Drug | Mechanism | Notes/Adverse Effects |
|---|---|---|
| Dobutamine | β1 agonist (↑ contractility & HR), mild β2 (vasodilation) | May cause tachyarrhythmias; can worsen hypotension due to vasodilation |
| Dopamine | Dose-dependent stimulation: Dopaminergic → β1 → α1 | Versatile; can improve contractility and vascular tone; risk of arrhythmias |
| Epinephrine | Potent α & β agonist | Strong inotrope & vasopressor; increases myocardial O2 demand and tachyarrhythmias |
| Phosphodiesterase inhibitors (e.g., milrinone) | ↑ cAMP → ↑ contractility & vasodilation | Less tachyarrhythmia risk than dobutamine; may cause hypotension |
Common Vasopressors
| Drug | Mechanism | Clinical Use & Notes |
|---|---|---|
| Norepinephrine | Potent α1 agonist (vasoconstriction), mild β1 effect | First-line in vasodilatory shock (septic shock); increases BP with less tachycardia |
| Phenylephrine | Pure α1 agonist | Useful for vasodilatory shock; may reduce stroke volume due to increased afterload; risk of tachyphylaxis |
| Vasopressin | Vasopressin receptor agonist | Adjunct in refractory septic shock; bypasses catecholamine receptors; may enhance sensitivity to catecholamines |
Clinical Application
- Cardiogenic Shock Management :
- Optimize volume status (careful fluid management).
- Use inotropes to increase myocardial contractility and cardiac output.
- Vasopressors may be needed if hypotension persists due to vasodilation.
- Inotropes can increase myocardial oxygen consumption, potentially worsening ischemia, so titration and careful monitoring are critical.
| Drug | Primary Action | Key Clinical Point | Main Risk |
|---|---|---|---|
| Dobutamine | ↑ Contractility & HR | Good for cardiac failure; caution if hypotensive | Tachyarrhythmias, hypotension |
| Dopamine | Dose-dependent effects | Flexible dosing, useful in shock | Arrhythmias |
| Epinephrine | ↑ Contractility & Vasoconstriction | Useful in shock, potent | ↑ Myocardial O2 demand |
| Milrinone | ↑ Contractility + Vasodilation | Useful in heart failure | Hypotension, arrhythmias |
| Norepinephrine | Vasoconstriction + Mild ↑ HR | First-line vasopressor in septic shock | Excess vasoconstriction |
| Phenylephrine | Pure Vasoconstriction | Avoid if stroke volume low | Tachyphylaxis, decreased CO |
| Vasopressin | Vasoconstriction via vasopressin receptors | Adjunct in refractory shock | Hyponatremia, ischemia |
